Literature DB >> 16413786

Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells.

Chuandong Fan1, Weiwei Wang, Baoxiang Zhao, Shangli Zhang, Junying Miao.   

Abstract

To investigate the effects of chloroquine diphosphate (CQ) on lung cancer cell growth, we treated A549 cells, a lung cancer cell line, with the drug at various concentrations (0.25-128 microM) for 24-72 h. The results showed that, at lower concentrations (from 0.25 to 32 microM), CQ inhibited the growth of A549 cells and, at the same time, it induced vacuolation with increased volume of acidic compartments (VAC). On the other hand, at higher concentrations (64-128 microM), CQ induced apoptosis at 24 h, while its effect of inducing vacuolation declined. The lactate dehydrogenase (LDH) assay showed that with the treatment of CQ 32-64 microM for 72 h or 128 microM for 48 h, CQ induced necrosis of A549 cells. To understand the possible mechanism by which CQ acts in A549 cells, we further incubated the cells with this drug at the concentrations of 32 or 128 microM in the presence of D609, a specific inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC). The results showed that D609 (50 microM) could inhibit the effects of CQ 32 microM on the viability and VAC, but it could not change the effects of CQ 128 microM on the same. Our data suggested that CQ inhibited A549 lung cancer cell growth at lower concentrations by increasing the volume of lysosomes and that PC-PLC might be involved in this process. The data also indicated that, at higher concentrations, CQ induced apoptosis and necrosis, but at this time its ability to increase the volume of lysosome gradually declined, and PC-PLC might not be implicated in the process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413786     DOI: 10.1016/j.bmc.2005.12.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  60 in total

1.  Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.

Authors:  Maribel Navarro; William Castro; Angel R Higuera-Padilla; Anibal Sierraalta; María Jesús Abad; Peter Taylor; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-09-22       Impact factor: 4.155

2.  Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.

Authors:  Ljubica Harhaji-Trajkovic; Katarina Arsikin; Tamara Kravic-Stevovic; Sasa Petricevic; Gordana Tovilovic; Aleksandar Pantovic; Nevena Zogovic; Biljana Ristic; Kristina Janjetovic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2012-04-27       Impact factor: 4.200

3.  Signaling of chloroquine-induced stress in the yeast Saccharomyces cerevisiae requires the Hog1 and Slt2 mitogen-activated protein kinase pathways.

Authors:  Shivani Baranwal; Gajendra Kumar Azad; Vikash Singh; Raghuvir S Tomar
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

4.  Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

Authors:  Xiaoyan Liang; Michael E De Vera; William J Buchser; Antonio Romo de Vivar Chavez; Patricia Loughran; Donna Beer Stolz; Per Basse; Tao Wang; Bennett Van Houten; Herbert J Zeh; Michael T Lotze
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

5.  Chloroquine affects autophagy to achieve an anticancer effect in EC109 esophageal carcinoma cells in vitro.

Authors:  Yan Cai; Jiajing Cai; Qiang Ma; Yuan Xu; Jiang Zou; Lei Xu; Dongsheng Wang; Xiaolan Guo
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

6.  Temsirolimus and chloroquine cooperatively exhibit a potent antitumor effect against colorectal cancer cells.

Authors:  Manabu Kaneko; Hiroaki Nozawa; Masaya Hiyoshi; Noriko Tada; Koji Murono; Takako Nirei; Shigenobu Emoto; Junko Kishikawa; Yuuki Iida; Eiji Sunami; Nelson H Tsuno; Joji Kitayama; Koki Takahashi; Toshiaki Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-12       Impact factor: 4.553

7.  Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner.

Authors:  Silvia Würstle; Fabian Schneider; Florian Ringel; Jens Gempt; Friederike Lämmer; Claire Delbridge; Wei Wu; Jürgen Schlegel
Journal:  Oncol Lett       Date:  2017-05-02       Impact factor: 2.967

8.  Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.

Authors:  Mingliang He; Ming Luo; Qingyu Liu; Jingkao Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Leping Ouyang; Anmin Liu
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

9.  Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.

Authors:  Kazuhito Sasaki; Nelson H Tsuno; Eiji Sunami; Giichiro Tsurita; Kazushige Kawai; Yurai Okaji; Takeshi Nishikawa; Yasutaka Shuno; Kumiko Hongo; Masaya Hiyoshi; Manabu Kaneko; Joji Kitayama; Koki Takahashi; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2010-07-15       Impact factor: 4.430

10.  Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells.

Authors:  Ella L Kim; Robin Wüstenberg; Anne Rübsam; Christoph Schmitz-Salue; Gabriele Warnecke; Eva-Maria Bücker; Nadine Pettkus; Daniel Speidel; Veit Rohde; Walter Schulz-Schaeffer; Wolfgang Deppert; Alf Giese
Journal:  Neuro Oncol       Date:  2010-01-27       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.